Skip to main content

Animations

MJFF Publications

7411 - 7420 of 8571 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2020
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imaging
    Journal Name: Seminars in Arthritis and Rheumatism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.semarthrit.2021.08.004
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Genetic control of the human brain proteome
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2021.01.012
    Citation Count: 86
  • Summary Details
    OPEN
    Title: Pervasive cis effects of variation in copy number of large tandem repeats on local DNA methylation and gene expression
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2021.03.016
    Citation Count: 33
  • Summary Details
    RESTRICTED
    Title: The Importance of Cross-Disciplinary Research: A Commentary on “Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease”
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2021.01.010
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Optimal Treatment of Depression and Anxiety in Parkinson's Disease
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2021.02.037
    Best OA location URL:
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30489-0
    Citation Count: 113
  • Summary Details
    OPEN
    Title: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002
    Citation Count: 5
  • Summary Details
    OPEN
    Title: A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.013
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.016
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.018
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.